SCHEMBL7260644

SCHEMBL7260644

CCOC(=O)Cn1cc(-c2ccc(OC)cc2)c(=O)c2c(OC)cc(OC)cc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.50
ALDH1A1 P00352 5/20 0.45
KDM4E B2RXH2 4/20 0.45
RAB9A P51151 3/20 0.45
NPC1 O15118 2/20 0.45
CYP3A4 P08684 2/20 0.45
HSD17B10 Q99714 2/20 0.45
PDE4B Q07343 1/20 0.44
PDE4D Q08499 1/20 0.44
CLK1 P49759 1/20 0.41
MAPT P10636 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 1/20 0.39
GNRHR P30968 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7532023 0.87 EGFR (0.48) EGFRALDH1A1KDM4ERAB9ANPC1
SCHEMBL7257558 0.87 TSPO (0.45) EGFRALDH1A1KDM4ERAB9ANPC1
SCHEMBL7262276 0.84 PDE4B (0.51) EGFRALDH1A1KDM4ERAB9ANPC1
SCHEMBL7257548 0.83 RAB9A (0.43) EGFRALDH1A1KDM4ERAB9ANPC1
SCHEMBL7261259 0.82 EGFR (0.48) EGFRALDH1A1KDM4ERAB9ANPC1
SCHEMBL7536631 0.81 CASP3 (0.47) EGFRALDH1A1KDM4ERAB9ANPC1
SCHEMBL7260717 0.78 ALDH1A1 (0.48) EGFRALDH1A1KDM4ERAB9ANPC1
SCHEMBL7256749 0.78 ALDH1A1 (0.48) EGFRALDH1A1KDM4ERAB9ANPC1
SCHEMBL7261248 0.77 ALDH1A1 (0.46) EGFRALDH1A1KDM4ERAB9ANPC1
SCHEMBL7257604 0.77 ALDH1A1 (0.46) EGFRALDH1A1KDM4ERAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645983-B1 Heterocyclic imines such as 3-(4-methoxyphenyl)-1,4-dihydro-4 -quinolinone, used as anticarcinogenic agents having cytolysis efficiency; side effect reduction LABORATOIRE L. LAFON (FR) 2003-11-11 US disclosed